Common Contracts
7 similar Change in Control, Bonus and Severance Agreement contracts by Anika Therapeutics Inc
Form of Change in Control, Bonus and Severance AgreementChange in Control, Bonus and Severance Agreement • July 12th, 2005 • Anika Therapeutics Inc • Surgical & medical instruments & apparatus • Massachusetts
AGREEMENT made as of July 11, 2005 by and among Anika Therapeutics, Inc., a Massachusetts corporation with its principal place of business in Woburn, Massachusetts (the “Company”), and Kevin W. Quinlan, with his principal residence in Marblehead, MA, (the “Executive”), an individual presently employed as the Chief Financial Officer of the Company.
ANIKA THERAPEUTICS, INC. Form of Change in Control, Bonus and Severance AgreementChange in Control, Bonus and Severance Agreement • November 19th, 2004 • Anika Therapeutics Inc • Biological products, (no disgnostic substances) • Massachusetts
AGREEMENT made as of October 6, 2004 by and among Anika Therapeutics, Inc., a Massachusetts corporation with its principal place of business in Woburn, Massachusetts (the “Company”), and Carol A. Toth, of East Walpole, Massachusetts (the “Executive”), an individual presently employed as the Senior Vice President Marketing and Business Development of the Company.
Form of Change in Control, Bonus and Severance AgreementChange in Control, Bonus and Severance Agreement • October 5th, 2004 • Anika Therapeutics Inc • Biological products, (no disgnostic substances) • Massachusetts
AGREEMENT made as of September 16, 2004 by and among Anika Therapeutics, Inc., a Massachusetts corporation with its principal place of business in Woburn, Massachusetts (the “Company”), and Elizabeth Chen, of Lexington, Massachusetts (the “Executive”), an individual presently employed as the Senior Vice President Marketing and Business Development of the Company.
ANIKA THERAPEUTICS, INC. Form of Change in Control, Bonus and Severance AgreementChange in Control, Bonus and Severance Agreement • August 14th, 2003 • Anika Therapeutics Inc • Biological products, (no disgnostic substances) • Massachusetts
AGREEMENT made as of June 9, 2003 by and among Anika Therapeutics, Inc., a Massachusetts corporation with its principal place of business in Woburn, Massachusetts (the “Company”), and Francesco (Frank) J. Luppino, of Melrose, MA (the “Executive”), an individual presently employed as the Vice President Operations of the Company.
Form of Change in Control, Bonus and Severance AgreementChange in Control, Bonus and Severance Agreement • May 15th, 2003 • Anika Therapeutics Inc • Biological products, (no disgnostic substances) • Massachusetts
AGREEMENT made as of March 17, 2003 by and among Anika Therapeutics, Inc., a Massachusetts corporation with its principal place of business in Woburn, Massachusetts (the “Company”), and Roger C. Stikeleather, of Doylestown, Pennsylvania (the “Executive”), an individual presently employed as the Vice President Sales and Marketing of the Company.
ANIKA THERAPEUTICS, INC. Change in Control, Bonus and Severance AgreementChange in Control, Bonus and Severance Agreement • August 14th, 2002 • Anika Therapeutics Inc • Biological products, (no disgnostic substances) • Massachusetts
AGREEMENT made as of July 8, 2002 by and among Anika Therapeutics, Inc., a Massachusetts corporation with its principal place of business in Woburn, Massachusetts (the “Company”), and William J. Knight of Boxford, Massachusetts (the “Executive”), an individual presently employed as the Chief Financial Officer, Vice President of Finance, Treasurer and Clerk of the Company.
ANIKA THERAPEUTICS, INC. First Amended and Restated Change in Control, Bonus and Severance AgreementChange in Control, Bonus and Severance Agreement • August 14th, 2002 • Anika Therapeutics Inc • Biological products, (no disgnostic substances) • Massachusetts
FIRST AMENDMENT AND RESTATEMENT, dated as of July 8, 2002 to that certain AGREEMENT made as of April 26, 2000 by and among Anika Therapeutics, Inc., a Massachusetts corporation with its principal place of business in Woburn, Massachusetts (the “Company”), and Charles H. Sherwood of Sudbury, Massachusetts (the “Executive”), an individual presently employed as the President and Chief Executive Officer of the Company.
